Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Comprehensive competitive analysis and profiles of major market players such as F. Hoffmann-La Roche AG, Bayer AG, Pfizer, Inc., Novartis AG and others, are also provided in the report.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/1501
๐๐๐ ๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global kidney cancer drugs market
- Extensive research is done for the market by therapy type which instils a clear understanding regarding the currently used targeted therapy drugs, evolving role of immunotherapies and in-line extensions opted for existing drugs
- The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
- The studies evaluating competitive landscape and value chain has been taken into account in this report to help in understanding the competitive environment across the geographies
- A detailed SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
- Owing to an emerging pipeline in the kidney cancer drugs market, clinical studies have also been taken into account to better understand the market potential and opportunities
- The kidney cancer drugs market scenario is comprehensively analyzed in accordance with the key regions
- Competitive intelligence highlights the business practises followed by leading market players across geographies
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1501
The market is expected to register substantial growth in the near future. This can be attributed to the various strategies adopted by the leading industry players. One of the key strategies adopted is collaboration agreement. Recently, Roche signed an agreement with Celldex Therapeutics, Inc. in order to evaluate the safety and efficacy of its immunotherapy drug, namely, MPDL3280A in combination with latters CD27 targeting investigational antibody, varlilumab for the treatment of renal cell carcinoma.
To provide a detailed market assessment, the report segments the kidney cancer drugs market on the basis of therapy type and geography. On the basis of therapy type, the market is segmented into Targeted Therapy, Chemotherapy and Immunotherapy. The report covers a geographic breakdown and a detailed analysis of each of the aforesaid segments across North America, Europe, Asia Pacific, and LAMEA.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com